Other inhibitors of the Wnt signalling pathways including Dkk-4, which has been recently shown to be expressed in primary breast tumours (Wirths et al, 2003; Katoh and Katoh, 2005) could also play a role in the pathogenesis of breast cancer bone metastases. Here, DKK4 is linked to breast carcinoma.